Monocyte-to-lymphocyte ratio: a potential novel predictor for acute kidney injury in the intensive care unit

Ren Fail. 2022 Dec;44(1):1004-1011. doi: 10.1080/0886022X.2022.2079521.

Abstract

Monocyte-to-lymphocyte ratio (MLR) and neutrophil-to-lymphocyte ratio (NLR) are considered as surrogate inflammatory indexes. Previous studies indicated that NLR was associated with the development of septic acute kidney injury (AKI). The objective of the present study was to explore the value of MLR and NLR in the occurrence of AKI in intensive care unit (ICU) patients. The clinical details of adult patients (n = 1500) who were admitted to the ICU from January 2016 to December 2019 were retrospectively examined. AKI was diagnosed according to the Kidney Disease: Improving Global Outcomes criteria. The development of AKI was the main outcome, and the secondary outcome was in-hospital mortality. Overall, 615 (41%) patients were diagnosed with AKI. Both MLR and NLR were positively correlated with AKI incidence (p < 0.001). Multivariate logistic regression analysis suggested that the risk value of MLR for the occurrence of AKI was nearly three-fold higher than NLR (OR = 3.904, 95% CI: 1.623‒9.391 vs. OR = 1.161, 95% CI: 1.135‒1.187, p < 0.001). The areas under the receiver operating characteristic curve (AUC) for MLR and NLR in the prediction of AKI incidence were 0.899 (95% CI: 0.881‒0.917) and 0.780 (95% CI: 0.755‒0.804) (all p < 0.001), with cutoff values of 0.693 and 12.4. However, the AUC of MLR and NLR in the prediction of in-hospital mortality was 0.583 (95% CI: 0.546‒0.620, p < 0.001) and 0.564 (95% CI: 0.528‒0.601, p = 0.001). MLR, an inexpensive and widely available parameter, is a reliable biomarker in predicting the occurrence of AKI in ICU patients.

Keywords: Monocyte; acute kidney injury; inflammation; intensive care unit; lymphocyte; neutrophil.

MeSH terms

  • Acute Kidney Injury* / diagnosis
  • Adult
  • Humans
  • Intensive Care Units
  • Lymphocytes
  • Monocytes*
  • Neutrophils
  • Prognosis
  • ROC Curve
  • Retrospective Studies

Grants and funding

This study was supported by the Hunan Provincial Health Commission Technology Foundation [202103050110 and 202103052372]; Hunan Provincial Science Technology Foundation [2020JJ4550]; Hengyang City Guidance plan Program [202121034630]; Natural Science Foundation of Guangdong Province [2019A1515010286]; GDPH Supporting Fund for Talent Program [DFJH201916]; National Natural Science Foundation of China [81970625].